- Condition: Posttraumatic Stress Disorder
Interventions: Behavioral: Prolonged exposure (PE); Other: PE plus Sertraline
Sponsors: Case Western Reserve University; Case Western Reserve University; University of Washington; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Conditions: Obesity; Overweight
Interventions: Drug: NB32; Drug: PBO; Behavioral: Weight Management Program
Sponsors: Orexigen Therapeutics, Inc; Orexigen Therapeutics, Inc
Not yet recruiting - verified May 2012 - Conditions: Hyperhydrosis; Depression
Intervention: Drug: Glycopyrrolate
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified April 2012 - Condition: Depressive Disorder, Major
Intervention: Behavioral: Medlink system
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Not yet recruiting - verified March 2012 - Condition: Acute Low Back Pain
Interventions: Drug: Naproxen; Drug: Cyclobenzaprine; Drug: Oxycodone/ acetaminophen
Sponsors: Montefiore Medical Center; Montefiore Medical Center
Recruiting - verified April 2012 - Condition: Diabetic Neuropathic Pain
Interventions: Drug: ABT-652 6 mg; Drug: ABT-652 12 mg; Drug: ABT-652 12 mg - 18 mg; Drug: Placebo comparator; Drug: Duloxetine
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Ketamine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Cigarette Smoking
Interventions: Drug: Nicotine replacement therapy - transdermal nicotine patch; Behavioral: Tailored behavioral intervention; Behavioral: Tobacco quitline referral; Drug: Nicotine replacement therapy - nicotine gum; Drug: Nicotine replacement therapy - nicotine lozenge; Drug: Bupropion SR; Drug: Varenicline; Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine gum; Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge; Drug: Combination pharmacotherapy - transdermal nicotine patch + bupropion; Behavioral: Alcohol use risk reduction; Behavioral: Behavioral activation for the treatment of depression; Behavioral: Behavioral management of post-cessation weight gain
Sponsors: University of Iowa; University of Iowa; Department of Veterans Affairs
Not yet recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; ElMindA Ltd
Recruiting - verified April 2012 - Conditions: Depressive Disorder; Depressive Disorder, Major; Depression
Intervention: Other: Citalopram
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Depressive Disorder, Major
Interventions: Drug: LuAA21004; Drug: Duloxetine; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Conditions: Cigarette Smoking; Nicotine Dependence
Interventions: Drug: varenicline (Chantix); Drug: bupropion (Zyban) & nicotine patches; Drug: nicotine patches
Sponsors: Duke University; Duke University; Philip Morris USA, Inc.
Recruiting - verified May 2012 - Conditions: MDD; Citalopram; Major Depressive Disorder
Intervention: Drug: citalopram
Sponsors: Mclean Hospital; Mclean Hospital
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Ketamine; Drug: Ketamine; Drug: Ketamine; Drug: Ketamine; Drug: Ketamine; Drug: Saline
Sponsors: Columbia University; Columbia University; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Osteoarthritis
Interventions: Drug: duloxetine; Drug: sugar pill
Sponsors: Northwestern University; Northwestern University; Eli Lilly and Company
Recruiting - verified March 2012 - Condition: Small Cell Lung Carcinoma
Intervention: Drug: lithium carbonate
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified May 2012 - Conditions: Bipolar I Disorder; Bipolar II Disorder
Interventions: Drug: Lithium/Lithium Carbonate; Drug: Divalproex; Drug: Lamotrigine; Drug: Quetiapine
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Treatment Resistant Depression
Intervention: Genetic: Genotyping assays
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified March 2012 - Conditions: Dysthymic Disorder; Dysthymia; Depression NOS; Chronic Depressive Disorder
Interventions: Drug: Desvenlafaxine; Drug: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; Pfizer
Recruiting - verified February 2012 - Condition: Hot Flashes in Men With Prostate Cancer Receiving Androgen Ablation Therapy
Interventions: Drug: Gabapentin; Drug: Venlafaxine
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: Sertraline; Behavioral: Prolonged Exposure Therapy
Sponsors: VA Ann Arbor Healthcare System; VA Ann Arbor Healthcare System; U.S. Army Medical Research and Materiel Command
Recruiting - verified May 2012 - Condition: Spinal Cord Injury
Interventions: Drug: escitalopram oxalate; Drug: Cyproheptadine; Drug: sugar pill; Other: Graded intensity exercise
Sponsors: Rehabilitation Institute of Chicago; T. George Hornby; University of Medicine and Dentistry New Jersey; Rehabilitation Institute of Chicago
Recruiting - verified February 2012 - Condition: Bipolar Disorder
Interventions: Drug: Lithium; Drug: Quetiapine
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Recruiting - verified January 2012 - Condition: Depression
Interventions: Behavioral: Sleep scheduling; Drug: Fluoxetine
Sponsors: University of Michigan; University of Michigan
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461; Drug: Placebo
Sponsors: Alkermes; Alkermes
Recruiting - verified April 2012 - Condition: Anorexia
Interventions: Drug: megestrol acetate; Drug: Arm B (megestrol plus mirtazapine)
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified April 2012 - Conditions: Migraine; Migraine Disorders; Headache
Interventions: Drug: Amitriptyline; Drug: Topiramate; Drug: Placebo
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: AZD6765 iv; Drug: AZD6765 iv; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Conditions: Knee Osteoarthritis; Degenerative Joint Disease; Chronic Pain
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Rehabilitation Institute of Chicago; Dr. Norman Harden; Forest Laboratories
Recruiting - verified January 2012 - Condition: Bipolar I Disorder
Intervention: Drug: Lithium/Matching Placebo and an SGA (Second Generation Antipsychotic)
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Vilazodone; Drug: Vilazodone; Drug: Citalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: cariprazine; Drug: cariprazine; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Gedeon Richter Ltd.
Recruiting - verified March 2012 - Condition: Irritable Bowel Syndrome
Interventions: Drug: Milnacipran; Drug: Milnacipran; Drug: Milnacipran; Drug: Placebo
Sponsors: University of North Carolina, Chapel Hill; Spencer Dorn, MD, MPH; Forest Laboratories
Recruiting - verified January 2012 - Condition: Fragile X Syndrome
Interventions: Drug: Sertraline; Drug: Placebo
Sponsors: University of California, Davis; University of California, Davis
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Intervention:
Sponsors: University of Utah; Paul Carlson; Western Institute for Biomedical Research; Brain Institute, University of Utah; University of Utah; Molecular Imaging Program, Huntsman Cancer Institute
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Iloperidone; Drug: Placebo
Sponsors: Massachusetts General Hospital; Maurizio Fava, MD; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Depression Disorder, Major
Interventions: Drug: RO4995819; Drug: RO4995819; Drug: RO4995819; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Cocaine Dependence
Interventions: Drug: Citalopram; Drug: Citalopram; Drug: Placebo
Sponsors: The University of Texas Health Science Center, Houston; Joy Schmitz; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Smoking Cessation
Interventions: Drug: Placebo; Drug: varenicline tartrate; Drug: bupropion hydrochloride; Drug: Nicotine Replacement Therapy Patch
Sponsors: Pfizer; Pfizer; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Pelvis Pain Chronic
Intervention: Drug: Duloxetine
Sponsors: University of Maryland; University of Maryland; Eli Lilly and Company
Recruiting - verified October 2011 - Condition: Depression Disorder, Major
Interventions: Drug: RO4917523; Drug: RO4917523; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Intervention: Device: Genecept Assay
Sponsors: Genomind, LLC; Genomind, LLC
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 30 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 50 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 70 mg; Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate ); Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Conditions: Major Depressive Disorder; Dysthymia
Interventions: Behavioral: Stepped Care IPT-A (SCIPT-A); Behavioral: Treatment as Usual
Sponsors: Columbia University; Columbia University; National Institute of Mental Health (NIMH)
Recruiting - verified September 2011 - Condition: Bipolar Depression
Interventions: Drug: ESC + CBX; Drug: ESC + PBO.; Drug: ESC+CBX
Sponsors: Loyola University; Loyola University; Stanley Medical Research Institute
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: desvenlafaxine succinate sustained-release 50 mg/day; Drug: desvenlafaxine succinate sustained-release 100 mg/day; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Fibromyalgia
Interventions: Drug: Pregabalin; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Bipolar Disorder I or II
Intervention: Drug: Tranylcypromine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified September 2011 - Condition: Major Depressive Disorder
Intervention: Device: Genecept Assay
Sponsors: Genomind, LLC; Genomind, LLC
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsors: Wyss Institute at Harvard University; Wyss Institute at Harvard University; Massachusetts General Hospital; Martinos Center for Biomedical Imaging; Massachusetts Institute of Technology
Recruiting - verified April 2012 - Conditions: Hot Flashes; Menopause; Vasomotor Disturbance
Interventions: Drug: Low-dose 17-ß-estradiol; Drug: Venlafaxine XR; Drug: Placebo
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Institute on Aging (NIA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Complementary and Alternative Medicine (NCCAM); Office of Research on Women's Health (ORWH)
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Augmenting: Antidepressant + Aripiprazole; Drug: Augmenting: Antidepressant + Bupropion-SR; Drug: Switching: Bupropion-SR
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Conditions: Major Depressive Disorder; Bipolar Disorder
Interventions: Behavioral: Wake Therapy; Device: lightbox; Drug: Lithium Carbonate; Drug: Armodafinil
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified April 2012 - Condition: Depression
Interventions: Drug: Sertraline; Drug: Placebo; Drug: BupropionXL
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified April 2012 - Condition: Body Dysmorphic Disorder
Intervention: Procedure: PET scan and MRI scan
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Condition: Chronic Migraine
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Mercy Health Research; Mercy Health Research
Recruiting - verified September 2011 - Condition: Depression
Interventions: Behavioral: Yoga; Behavioral: Healthy Living Workshop
Sponsors: Butler Hospital; Butler Hospital; National Institute of Nursing Research (NINR)
Recruiting - verified November 2011 - Conditions: Depression; HIV
Intervention: Other: Measurement-Based Care collaborative depression management
Sponsors: Duke University; Duke University; National Institute of Mental Health (NIMH); University of North Carolina, Chapel Hill; University of Alabama at Birmingham
Recruiting - verified June 2011 - Conditions: Schizophrenia; Alcoholism; Dual Diagnosis
Interventions: Drug: Risperidone + Desipramine; Drug: Risperidone + Placebo
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center; University of South Carolina
Recruiting - verified December 2011 - Conditions: Osteoarthritis; Chronic Pain
Intervention: Drug: duloxetine, diclofenac
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Research Resources (NCRR); Merck; Nuvo Research Inc.
Recruiting - verified March 2012 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline; Drug: Bupropion; Drug: Nicotine patches
Sponsors: Duke University; Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Bipolar Affective Disorders; Cyclothymic Disorder; Schizoaffective Disorder; Major Depressive Disorder; Dysthymic Disorder; Obsessive-Compulsive Disorder; Panic Disorder; Posttraumatic Stress Disorder; Premenstrual Dysphoric Disorder; Social Anxiety Disorder
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Condition: Major Depressive Disorder
Interventions: Drug: desvenlafaxine succinate sustained release; Drug: fluoxetine; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Pregnancy Related; Tobacco Use Disorder
Interventions: Drug: bupropion SR 150 mg tablets or matched placebo; Behavioral: Smoking Cessation Counseling
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; National Institute on Drug Abuse (NIDA); University of Connecticut Health Center
Recruiting - verified August 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release; Drug: Desvenlafaxine Succinate Sustained-Release; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: DVS SR
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: DVS SR
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Escitalopram; Drug: BMS-820836 Placebo; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified August 2011 - Condition: Treatment Outcome
Interventions: Drug: Lu AA21004; Drug: Escitalopram
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Device: NEST-1 (NeoSync EEG Synchronized TMS); Device: SHAM
Sponsors: NeoSync, Inc.; NeoSync, Inc.
Recruiting - verified May 2012 - Conditions: TBI; Major Depression; Other Psychiatric Disorders
Intervention: Drug: Escitalopram
Sponsors: Johns Hopkins University; Johns Hopkins University; Forest Laboratories
Recruiting - verified February 2009 - Condition: Bipolar Disorder
Intervention: Drug: Lithium, valproate, lamotrigine
Sponsors: Emory University; Emory University
Recruiting - verified October 2011 - Conditions: Depressive Disorder; Depression; Depressive Disorder, Major; Mood Disorders; Mental Disorders
Interventions: Drug: OPC-34712 + ADT; Drug: Placebo + ADT; Drug: Placebo + ADT
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified July 2011 - Conditions: Depressive Disorder; Depression; Depressive Disorder, Major; Mood Disorders; Mental Disorders
Interventions: Drug: OPC-34712 + ADT; Drug: Placebo + ADT; Drug: Placebo + ADT
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified July 2011 - Condition: Methamphetamine Dependence
Interventions: Other: placebo; Drug: Naltrexone and Bupropion SR
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Conditions: Drug-Drug Interaction; Healthy Volunteers
Intervention: Drug: Fluoxetine
Sponsors: University of Washington; University of Washington; National Institute of General Medical Sciences (NIGMS)
Recruiting - verified April 2012 - Conditions: Systemic Lupus Erythematosus; Widespread Pain; Fibromyalgia
Intervention: Drug: Milnacipran
Sponsors: Loma Linda University; Emmanuel Katsaros; Forest Laboratories
Recruiting - verified October 2011 - Condition: Bipolar Disorder
Interventions: Drug: Lithium; Drug: Quetiapine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Analgesic Solutions; Analgesic Solutions; Forest Laboratories
Recruiting - verified August 2011 - Condition: Social Anxiety Disorder
Interventions: Drug: Pristiq; Drug: Placebo comparator
Sponsors: The Medical Research Network; The Medical Research Network; Pfizer
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: PNB01 fixed dose combination of pipamperone and citalopram; Drug: Citalopram; Drug: Pipamperone
Sponsors: PharmaNeuroBoost N.V.; PharmaNeuroBoost N.V.
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Behavioral: problem solving therapy; Drug: Sertraline
Sponsors: University of California, San Francisco; University of California, San Francisco; Leon J. Epstein Endowment
Recruiting - verified January 2012 - Conditions: Epilepsy; Anxiety
Interventions: Drug: Pregabalin-Lyrica; Drug: Sertraline
Sponsors: Rush University Medical Center; Rush University Medical Center
Recruiting - verified September 2011 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline; Drug: Bupropion; Drug: Nicotine patches; Drug: Nicotine Inhaler
Sponsors: Duke University; Duke University; National Institute on Drug Abuse (NIDA); Philip Morris USA, Inc.
Recruiting - verified March 2012 - Conditions: Vestibulodynia; Vulvodynia
Intervention: Drug: Milnacipran
Sponsors: University of Tennessee; University of Tennessee; Forest Laboratories
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Ketamine; Drug: placebo
Sponsors: Mount Sinai School of Medicine; James Murrough
Recruiting - verified December 2011 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Placebo matching with BMS-820836; Drug: BMS-820836; Drug: Duloxetine; Drug: Placebo matching with Duloxetine
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Fibromyalgia
Intervention: Drug: Milnacipran
Sponsors: University of Florida; University of Florida; Forest Laboratories
Recruiting - verified March 2012 - Condition: Idiopathic Peripheral Neuropathy
Intervention: Drug: Milnacipran
Sponsors: Columbia University; Columbia University; Forest Laboratories
Recruiting - verified February 2012 - Conditions: Smoking; Smoking Cessation
Interventions: Other: Coordinated Care; Other: Usual Care
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - verified September 2011 - Condition: Smoking Cessation
Intervention: Drug: Bupropion SR
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; M.D. Anderson Cancer Center; Larry C. Gilstrap, MD Center for Perinatal and Women's Health Research; The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston
Recruiting - verified February 2012 - Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified April 2012 - Condition: Systemic Lupus Erythematosus
Intervention: Drug: Cymbalta
Sponsors: Brain Resource Center; Brain Resource Center
Recruiting - verified December 2010 - Conditions: Autism Spectrum Disorder; Asperger Syndrome; Aspergers Syndrome
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Montefiore Medical Center; Montefiore Medical Center; Forest Laboratories
Recruiting - verified April 2012 - Condition: GERD
Interventions: Device: Nissen fundoplication; Drug: baclofen; Drug: Desipramine
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified January 2012 - Condition: Multiple Sclerosis
Intervention: Drug: Lithium Carbonate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Amisulpride; Drug: Placebo
Sponsors: Mclean Hospital; Mclean Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Conditions: Adenocarcinoma of the Prostate; Castrate Resistant Prostate Cancer; Recurrent Prostate Cancer
Interventions: Drug: docetaxel; Procedure: prostate biopsy; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Drug: phenelzine sulfate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Fibromyalgia
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13
Sponsors: Naurex, Inc; Naurex, Inc
Recruiting - verified June 2011 - Conditions: Sleep Disorders; Fibromyalgia; Sleep
Interventions: Drug: Milnacipran; Drug: Milnacipran
Sponsors: Cleveland Sleep Research Center; Mansoor Ahmed M.D.; Forest Laboratories
Recruiting - verified November 2010 - Condition: Smoking Cessation
Intervention: Behavioral: counseling vs. advice
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Milnacipran
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Forest Laboratories
Recruiting - verified February 2012 - Condition: Head And Neck Cancer
Interventions: Other: Placebo; Drug: Curcumin; Drug: Armodafinil; Drug: Minocycline; Drug: Bupropion
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified November 2011 - Conditions: Anxiety Neuroses; Anxiety States, Neurotic; Neuroses, Anxiety
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Roux en Y Gastric Bypass Surgery
Intervention: Drug: Sertraline
Sponsors: Neuropsychiatric Research Institute, Fargo, North Dakota; Neuropsychiatric Research Institute, Fargo, North Dakota; National Institutes of Health (NIH)
Recruiting - verified July 2011 - Conditions: Major Depressive Disorder; Dysthymia Disorder
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified September 2010 - Condition: Depression
Interventions: Drug: Riluzole; Drug: placebo
Sponsors: Yale University; Yale University
Recruiting - verified March 2012 - Condition: Chronic Oral Food Refusal
Interventions: Drug: Amitriptyline 1 mg/kg; Drug: Placebo
Sponsors: University of Kansas; Ann Davis, PhD, MPH, ABPP
Recruiting - verified March 2012 - Condition: Arthritis, Rheumatoid
Intervention: Drug: Milnacipran
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Forest Laboratories; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Intervention: Behavioral: Interactive voice messaging or Interactive voice messaging + psycho ed materials
Sponsors: Kaiser Permanente; Kaiser Permanente; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: Mirtazapine; Drug: Sertraline; Other: Sugar pill
Sponsors: Research Foundation for Mental Hygiene; Research Foundation for Mental Hygiene; National Institute of Mental Health (NIMH)
Recruiting - verified July 2010 - Condition: Bipolar Disorder
Interventions: Drug: Lithium Carbonate; Drug: Placebo
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Alcohol Dependence
Interventions: Drug: Quetiapine XR plus mirtazapine; Drug: Quetiapine fumarate extended release (Quetiapine XR)
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center
Recruiting - verified February 2012 - Conditions: Complicated Grief; Bereavement
Interventions: Drug: Citalopram; Behavioral: Complicated Grief Treatment; Other: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH); American Foundation for Suicide Prevention
Recruiting - verified March 2012 - Conditions: Social Phobia; Generalized Anxiety Disorder; Separation Anxiety Disorder
Intervention: Drug: Sertraline
Sponsors: University of Michigan; University of Michigan; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Conditions: Head and Neck Cancer; Mucositis; Oral Complications of Radiation Therapy; Pain
Interventions: Drug: doxepin hydrochloride; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Cervical Radiculopathy
Interventions: Other: Gabapentin and/or Nortriptyline, Physical therapy; Procedure: Epidural Steroid Injections (ESI); Other: Combination treatment
Sponsors: Johns Hopkins University; Johns Hopkins University; Walter Reed Army Medical Center
Recruiting - verified September 2010 - Conditions: Major Depressive Disorder; Suicidality
Interventions: Drug: paliperidone; Drug: placebo; Drug: lithium
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; American Foundation for Suicide Prevention; Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified March 2012 - Condition: Fibromyalgia
Interventions: Drug: Duloxetine; Procedure: Skin biopsy
Sponsors: Albany Medical College; Albany Medical College
Recruiting - verified December 2010 - Condition: Fibromyalgia
Interventions: Drug: Milnacipran; Procedure: Skin biopsy
Sponsors: Albany Medical College; Albany Medical College; Forest Laboratories
Recruiting - verified December 2010 - Conditions: Depression; Back Pain
Interventions: Other: Combination Treatment with Higher-dose venlafaxine + PST-DP; Drug: Higher-dose venlafaxine and supportive management
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified March 2012 - Condition: Generalized Anxiety Disorder
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Schizophrenia; Smoking Cessation
Interventions: Other: Sugar Pill; Drug: Varenicline; Drug: Bupropion HCl
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Brain Cancer
Intervention: Drug: Temozolomide, bevacizumab, lithium, radiation
Sponsors: New York University School of Medicine; New York University School of Medicine; Genentech; Ohio State University; Atlantic Health System
Recruiting - verified February 2012 - Condition: Fibromyalgia
Interventions: Drug: Minalcipran; Drug: Placebo
Sponsors: Beth Israel Medical Center; Beth Israel Medical Center; Forest Laboratories
Recruiting - verified January 2012 - Condition: Postoperative Pain
Intervention: Drug: cyclobenzaprine
Sponsors: NorthShore University HealthSystem Research Institute; NorthShore University HealthSystem Research Institute
Recruiting - verified March 2012 - Condition: Pregnancy
Intervention: Drug: duloxetine
Sponsors: Eli Lilly and Company; Eli Lilly and Company; INC Research, LLC
Recruiting - verified February 2012 - Condition: Nicotine Dependence
Interventions: Drug: Bupropion SR; Drug: Nicotine; Drug: Placebo pill and Placebo Patch; Other: Delayed-Quit Control
Sponsors: Southern Illinois University Carbondale; Southern Illinois University Carbondale; National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: Ad.p53 DC vaccine; Drug: 1-methyl-D-tryptophan (1-MT)
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Schizophrenia; Schizophreniform Disorder
Interventions: Drug: Citalopram; Behavioral: Psychoeducation; Behavioral: Cognitive Behavioral Therapy (CBT); Radiation: Functional Magnetic Resonance Imaging (fMRI); Drug: Placebo; Behavioral: Psychoeducation; Behavioral: Cognitive Behavioral Therapy (CBT); Radiation: Functional Magnetic Resonance Imaging (fMRI)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Intervention: Drug: tranylcypromine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Conditions: Major Depression; Treatment
Interventions: Drug: Sertraline; Behavioral: Cognitive Behavioral Therapy
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Depression
Interventions: Drug: lithium and Venlafaxine; Procedure: ECT
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Depression
Interventions: Behavioral: Shared Decision Making; Other: Usual Care
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Fibromyalgia
Intervention:
Sponsors: INC Research; INC Research; Forest Laboratories
Recruiting - verified March 2012 - Conditions: Heart Failure; Depression
Interventions: Behavioral: Cognitive Behavior Therapy; Other: Heart Failure Self-care Education
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Hot Flashes
Interventions: Drug: venlafaxine; Drug: placebo; Procedure: hypnotherapy; Procedure: mind-body intervention procedure
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Back Pain
Interventions: Behavioral: cognitive behavioral therapy; Drug: desipramine hydrochloride; Behavioral: cognitive behavioral therapy; Drug: benztropine mesylate 0.125 mg daily; Drug: desipramine hydrochloride
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of California, San Diego
Recruiting - verified April 2012 - Condition: Major Depressive Disorder With Psychotic Features
Interventions: Drug: Quetiapine monotherapy; Drug: Quetiapine with SSRI
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Intervention: Drug: escitalopram and adjunctive aripiprazole and placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Conditions: Chronic Kidney Disease; Depression
Interventions: Drug: Sertraline; Drug: placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Texas Southwestern Medical Center
Recruiting - verified May 2012 - Condition: Smoking Cessation
Interventions: Drug: Varenicline; Drug: Bupropion; Other: Placebo; Behavioral: Counseling/Phone Calls
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Condition: Alcohol Dependence
Interventions: Drug: Pregabalin; Drug: Duloxetine; Behavioral: Standardized behavioral therapy; Behavioral: Standardized behavioral therapy; Drug: Placebo; Behavioral: Standardized behavioral therapy
Sponsors: The Scripps Research Institute; The Scripps Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified June 2011 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Marijuana Abuse
Intervention: Drug: bupropion, diazepam, dronabinol, ramelteon (Investigational Drug)
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2009 - Condition: Short Bowel Syndrome
Intervention: Drug: Citalopram
Sponsors: University of Nebraska; University of Nebraska
Recruiting - verified August 2011 - Condition: Major Depressive Disorder
Intervention: Drug: Creatine Monohydrate
Sponsors: University of Utah; University of Utah; AlzChem, LLC
Recruiting - verified April 2012 - Condition: Postpartum Depression
Intervention: Drug: Escitalopram
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Forest Laboratories
Recruiting - verified July 2011 - Conditions: Convulsion, Non-Epileptic; Conversion Disorder; Depression; Stress Disorders, Post-Traumatic; Dissociative Disorders
Interventions: Drug: sertraline; Behavioral: CBT for NES; Other: Med+CBT; Other: Standard Care
Sponsors: Rhode Island Hospital; Rhode Island Hospital; American Epilepsy Society; Epilepsy Foundation; University of Cincinnati; Stanford University
Recruiting - verified July 2011 - Conditions: Obesity; Binge Eating
Interventions: Behavioral: Behavioral Weight Loss; Behavioral: Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy; Drug: Placebo; Drug: Sibutramine
Sponsors: Yale University; Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Mood Disorder; Mental Disorder Diagnosed in Childhood; Attention Deficit and Disruptive Behavior Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Citalopram; Drug: Methylphenidate
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Condition: Idiopathic Gastroparesis
Interventions: Drug: Nortriptyline Hydrochloride; Drug: Nortriptyline-Placebo
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressants through Texas Medication Algorithm (TMA); Behavioral: Brief Interpersonal Psychotherapy (IPT-B)
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Breast Cancer; Lung Cancer; Melanoma; Pancreatic Cancer; Solid Tumors
Intervention: Drug: 1-methyl-D-tryptophan
Sponsors: NewLink Genetics Corporation; NewLink Genetics Corporation
Recruiting - verified December 2011 - Condition: Traumatic Brain Injury
Interventions: Drug: Placebo; Drug: Sertraline
Sponsors: University of Iowa; University of Iowa; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2012 - Condition: Depression
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Venlafaxine XR
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified March 2012 - Conditions: Breast Cancer; Depression; Hot Flashes; Psychosocial Effects of Cancer and Its Treatment
Interventions: Drug: citalopram hydrobromide; Drug: escitalopram oxalate; Drug: gabapentin; Drug: sertraline hydrochloride; Drug: tamoxifen citrate; Drug: venlafaxine; Genetic: molecular genetic technique; Other: high performance liquid chromatography; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: adjuvant therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Psychotic Depression; Major Depression With Psychotic Features; Psychosis
Interventions: Drug: mifepristone; Drug: placebo
Sponsors: Corcept Therapeutics; Corcept Therapeutics
Recruiting - verified February 2012 - Conditions: Stress Disorders, Posttraumatic; Tobacco Use Disorder
Interventions: Drug: Nicotine; Behavioral: Cognitive Behavioral Therapy for Smoking Cessation; Drug: Bupropion SR
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Diabetic Neuropathic Pain; Chronic Low Back Pain
Interventions: Drug: donepezil; Drug: duloxetine; Drug: donepezil 2.5 mg and duloxetine 30mg; Drug: placebo; Drug: gabapentin
Sponsors: Wake Forest University; Wake Forest University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012 - Condition: Depression
Intervention: Drug: citalopram and escitalopram
Sponsors: Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH)
Recruiting - verified May 2012 - Conditions: Postpartum Depression; Major Depressive Disorder
Intervention: Drug: duloxetine
Sponsors: Yale University; Yale University
Recruiting - verified June 2011 - Condition: Chronic Pain
Intervention:
Sponsors: Rush University Medical Center; Asokumar Buvanendran
Recruiting - verified April 2012 - Condition: Depression, Postpartum
Interventions: Drug: Sertraline; Drug: Placebo; Behavioral: Interpersonal psychotherapy (IPT); Behavioral: Clinical management
Sponsors: Women and Infants Hospital of Rhode Island; Women and Infants Hospital of Rhode Island; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Smoking Lapse Behavior
Interventions: Drug: varenicline; Drug: bupropion; Drug: Placebo
Sponsors: Yale University; Yale University
Recruiting - verified January 2012 - Condition: Alcohol Drinking
Interventions: Drug: varenicline; Drug: bupropion; Drug: placebo
Sponsors: Yale University; Yale University
Recruiting - verified January 2012 - Condition: Medullary Thyroid Cancer
Intervention: Drug: Lithium carbonate
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified November 2011 - Condition: Depression
Interventions: Drug: Standard antidepressant therapy (SADT); Behavioral: Motivational antidepressant therapy (MADT)
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Conditions: Bipolar Disorder; Bipolar Depression
Interventions: Drug: citalopram + mood stabilizer; Procedure: FDG PET scans; Procedure: MRI structural scans; Procedure: Genotyping; Procedure: Blood Draw; Drug: placebo + mood stabilizer
Sponsors: Tufts Medical Center; Tufts Medical Center; National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Condition: Premenstrual Dysphoric Disorder
Interventions: Drug: Sertraline; Drug: Placebo
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified June 2011 - Conditions: Obesity; Binge Eating
Interventions: Drug: Sibutramine; Drug: Placebo; Behavioral: Self-help CBT + Sibutramine; Behavioral: Self-help CBT + Placebo
Sponsors: Yale University; Yale University; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Conditions: Advanced Cancer; Weight Loss
Intervention: Drug: Olanzapine
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified May 2012 - Condition: Obsessive Compulsive Disorder
Intervention: Drug: Duloxetine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eli Lilly and Company
Recruiting - verified July 2011 - Condition: Depression
Interventions: Drug: Escitalopram; Drug: Desipramine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Multiple Sclerosis
Intervention: Drug: Duloxetine
Sponsors: Brown, Theodore R., M.D., MPH; Brown, Theodore R., M.D., MPH; Eli Lilly and Company
Recruiting - verified October 2011 - Condition: Depression
Interventions: Drug: Paroxetine CR for major depressive episode; Drug: Bupropion XL for major depressive episode
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Unipolar Depression; Bipolar Depression
Intervention: Drug: Scopolamine
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Major Depressive Disorder; Healthy
Interventions: Procedure: PET scan; Drug: Rolipram
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified October 2011 - Condition: Depression
Interventions: Drug: Escitalopram; Drug: Duloxetine; Behavioral: Cognitive behavioral therapy (CBT)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Emory University
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Intervention: Drug: Sertraline (drug)
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Stress Disorders, Post-Traumatic; Alcohol Abuse; Substance-Related Disorders
Interventions: Behavioral: Seeking Safety; Drug: Sertraline, "Zoloft" and Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified October 2011 - Conditions: Tachycardia; Chronic Orthostatic Intolerance
Interventions: Drug: Acetazolamide; Drug: Atomoxetine; Other: Baseline (No Drug); Drug: Clonidine; Drug: Entacapone; Drug: Entacapone & Propranolol; Drug: Atomoxetine & Propranolol; Drug: Indomethacin; Drug: Mecamylamine; Drug: Isosorbide Dinitrate; Dietary Supplement: Melatonin; Drug: Midodrine; Drug: Modafinil; Drug: Octreotide; Radiation: Placebo; Drug: Propranolol; Drug: Modafinil & Propranolol; Drug: Sertraline; Procedure: IV Saline; Other: Drinking Water; Device: Breathing Device; Drug: memantine; Device: Abdominal binder
Sponsors: Vanderbilt University; Satish R. Raj; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: Functional Dyspepsia
Interventions: Drug: Amitriptyline; Drug: escitalopram; Drug: placebo
Sponsors: Mayo Clinic; Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Bipolar Disorder
Intervention: Drug: Lithium treatment
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Conditions: Cocaine Dependence; Depression
Interventions: Drug: Mirtazapine; Drug: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Condition: Body Dysmorphic Disorder
Interventions: Drug: Fluoxetine; Drug: Placebo
Sponsors: Montefiore Medical Center; Montefiore Medical Center; Food and Drug Administration (FDA)
Recruiting - verified September 2011 - Conditions: Schizophrenia; Schizoaffective Disorder; Major Depression; Bipolar Disorder; Coronary Artery Disease
Interventions: Drug: Eicosapentaenoic acid (omega-3 fatty acid); Drug: Placebo
Sponsors: University of Pittsburgh; University of Pittsburgh; American Heart Association; VA Pittsburgh Healthcare System
Recruiting - verified October 2011 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Anxiety Disorders; Somatoform Disorders
Interventions: Drug: Escitalopram; Drug: Placebo; Drug: Escitalopram extension
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Mental Health (NIMH); Rhode Island Hospital
Recruiting - verified May 2012 - Condition: Depressive Disorder, Major
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified October 2011 - Conditions: Depression; Major Depression/Bipolar Disorder
Interventions: Drug: Ketamine; Drug: Riluzole; Drug: FDG
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Conditions: Postpartum Depression; Depression
Intervention: Drug: 17 beta-estradiol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified September 2011 - Condition: Bipolar Disorder
Intervention: Drug: Riluzole
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified June 2011 - Conditions: Depression; Mood Disorder; Anxiety Disorder; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified October 2011
 |
Antidepressive Agents Clinical Trials |
